Savilova A M, Yushina M N, Rudimova Yu V, Khabas G N, Chuprynin V D, Sukhikh G T
V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation, Moscow, Russia.
Bull Exp Biol Med. 2016 Aug;161(4):610-5. doi: 10.1007/s10517-016-3469-0. Epub 2016 Sep 3.
Cell cultures isolated from endometriosis lesions by enzymatic dissociation consisted of fibroblast-like cells expressing CD90, CD73, and CD105; cell viability in these cultures was >90%, but this parameter decreased by passage 3. Zero passage cultures contained 10-25% epithelial cells expressing cytokeratin-7, but by passage 2, the cultures became more homogeneous and epithelial cells disappeared. The proportion of proliferating cells and population doubling level increased from passage 1 to passage 3. The cultures from the endometrium were induced to adipogenic and osteogenic differentiation in vitro. The cultures derived from ectopic endometrium have properties of multipotent mesenchymal stromal cells that exhibited in vitro similarities and differences from cell cultures from eutopic endometrium, which allows using this cell model for the search and testing of new drugs and technologies aimed at suppression of the growth and spread of endometriosis lesions.
通过酶解从子宫内膜异位症病变中分离出的细胞培养物由表达CD90、CD73和CD105的成纤维细胞样细胞组成;这些培养物中的细胞活力>90%,但到第3代时该参数下降。第0代培养物含有10-25%表达细胞角蛋白-7的上皮细胞,但到第2代时,培养物变得更加均一,上皮细胞消失。增殖细胞的比例和群体倍增水平从第1代到第3代增加。子宫内膜的培养物在体外被诱导向脂肪生成和成骨分化。源自异位子宫内膜的培养物具有多能间充质基质细胞的特性,与来自在位子宫内膜的细胞培养物相比,在体外表现出异同,这使得可以使用这种细胞模型来寻找和测试旨在抑制子宫内膜异位症病变生长和扩散的新药和新技术。